Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells

Jamie S. Mader; Daniel Smyth; Jean Marshall; David W. Hoskin

doi:10.2353/ajpath.2006.051229

Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor₁₆₅-induced angiogenesis by competing for heparin-like binding sites on endothelial cells

Jamie S. Mader, Daniel Smyth, Jean Marshall, David W. Hoskin

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	1753-1766
页数	14
期刊	American Journal of Pathology
卷	169
期	5
DOI	https://doi.org/10.2353/ajpath.2006.051229
出版状态	已出版 - 11月 2006
已对外发布	是

!!!ASJC Scopus Subject Areas

病理学与法医学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.2353/ajpath.2006.051229

其它文件与链接

引用此

Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor₁₆₅-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. / Mader, Jamie S.; Smyth, Daniel; Marshall, Jean 等.
在: American Journal of Pathology, 卷 169, 号码 5, 11.2006, 页码 1753-1766.

科研成果: 期刊稿件 › 文章 › 同行评审

@article{1bf23eb65ca848debce461ee7af5be55,

title = "Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells",

author = "Mader, {Jamie S.} and Daniel Smyth and Jean Marshall and Hoskin, {David W.}",

note = "Funding Information: Supported by the Canadian Breast Cancer Foundation, Atlantic Chapter (to D.W.H.) and the Nova Scotia Health Research Foundation and the Cancer Research Training Program with funding from the Dalhousie Cancer Research Program (studentships to J.S.M.). ",

year = "2006",

month = nov,

doi = "10.2353/ajpath.2006.051229",

language = "English",

volume = "169",

pages = "1753--1766",

journal = "American Journal of Pathology",

issn = "0002-9440",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells

AU - Mader, Jamie S.

AU - Smyth, Daniel

AU - Marshall, Jean

AU - Hoskin, David W.

N1 - Funding Information: Supported by the Canadian Breast Cancer Foundation, Atlantic Chapter (to D.W.H.) and the Nova Scotia Health Research Foundation and the Cancer Research Training Program with funding from the Dalhousie Cancer Research Program (studentships to J.S.M.).

PY - 2006/11

Y1 - 2006/11

UR - http://www.scopus.com/inward/record.url?scp=38348999283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38348999283&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2006.051229

DO - 10.2353/ajpath.2006.051229

M3 - Article

C2 - 17071598

AN - SCOPUS:38348999283

SN - 0002-9440

VL - 169

SP - 1753

EP - 1766

JO - American Journal of Pathology

JF - American Journal of Pathology

IS - 5

ER -